Trust Co. of Vermont Has $2.85 Million Position in CVS Health Co. (NYSE:CVS)

Trust Co. of Vermont lessened its position in shares of CVS Health Co. (NYSE:CVS) by 41.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,492 shares of the pharmacy operator’s stock after selling 44,876 shares during the quarter. Trust Co. of Vermont’s holdings in CVS Health were worth $2,850,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the 3rd quarter valued at about $25,000. Ridgewood Investments LLC boosted its stake in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the third quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health during the third quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $32,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Up 1.5 %

Shares of NYSE CVS traded up $0.76 during mid-day trading on Friday, reaching $52.72. 13,362,187 shares of the company’s stock traded hands, compared to its average volume of 13,670,579. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock has a market cap of $66.35 billion, a P/E ratio of 13.38, a PEG ratio of 0.72 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The business has a 50-day simple moving average of $51.39 and a 200 day simple moving average of $56.36.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period in the prior year, the firm posted $2.21 EPS. CVS Health’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, analysts expect that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.05%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on CVS shares. Truist Financial lowered their target price on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Mizuho cut their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Royal Bank of Canada dropped their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. Finally, UBS Group lifted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.